Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation.

The effect of consumption of red or white wine (11% alcohol) with meals on the propensity of plasma and low-density lipoprotein (LDL) to undergo lipid peroxidation was studied in 17 healthy men who were divided into two groups: 8 received 400 mL red wine/d for 2 wk, and 9 received a similar amount of white wine. Red wine consumption for 2 wk resulted in a 20% reduction in the propensity of plasma to undergo lipid peroxidation (in the presence of a free-radical-generating system) as determined by the thiobarbituric acid reactive substances (TBARS) assay. In parallel, red wine consumption reduced the propensity of the volunteers' LDL to undergo lipid peroxidation (in response to copper ions) as determined by a 46%, 72%, and 54% decrease in the content of TBARS, lipid peroxides, and conjugated dienes in LDL, respectively, as well as by a substantial prolongation of the lag phase required for the initiation of LDL oxidation. On the contrary, dietary consumption of white wine for 2 wk resulted in a 34% increase in plasma's propensity to undergo lipid peroxidation and also in a 41% increased propensity of the LDL to undergo lipid peroxidation. The antioxidant effect of dietary red wine on plasma lipid peroxidation was not secondary to changes in the plasma vitamin E or beta-carotene content but could be related to the elevation of polyphenol concentration in plasma and LDL. Thus, some phenolic substances that exist in red wine, but not in white wine, are absorbed, bind to plasma LDL, and may be responsible for the antioxidant properties of red wine.

[1]  W. Willett,et al.  Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. , 1993, The New England journal of medicine.

[2]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[3]  C. Abbott,et al.  The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. , 1993, The Biochemical journal.

[4]  M. Aviram,et al.  Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. , 1993, Annals of nutrition & metabolism.

[5]  A. Waterhouse,et al.  Inhibition of human LDL oxidation by resveratrol , 1993, The Lancet.

[6]  E. Parks,et al.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.

[7]  G. Lescoat,et al.  Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. , 1993, Biochemical pharmacology.

[8]  M. Aviram Modified forms of low density lipoprotein and atherosclerosis. , 1993, Atherosclerosis.

[9]  A. Lavy,et al.  Preferential Inhibition of LDL Oxidation by the all-trans Isomer of β-Carotene in Comparison with 9-cis β-Carotene , 1993 .

[10]  G. Bondjers,et al.  Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  M. Kuzuya,et al.  Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. , 1992, Biochimica et biophysica acta.

[12]  S. Brown,et al.  The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. , 1992, Biochemical pharmacology.

[13]  C. Derian,et al.  Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein. , 1992, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  R. Vandongen,et al.  Effects of alcohol intake on plasma fatty acids assessed independently of diet and smoking habits. , 1991, Clinical science.

[15]  D. Steinberg,et al.  Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. , 1991, Journal of lipid research.

[16]  N. Kaplowitz,et al.  Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. , 1991, The Journal of clinical investigation.

[17]  M. Aviram Effect of Lipoproteins and Platelets on Macrophage Cholesterol Metabolism , 1991 .

[18]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[19]  S. Rankin,et al.  Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. , 1990, Biochemical pharmacology.

[20]  L. Fong,et al.  High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. , 1990, Biochimica et biophysica acta.

[21]  D. Steinberg,et al.  Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  U. Steinbrecher,et al.  Role of oxidatively modified LDL in atherosclerosis. , 1990, Free radical biology & medicine.

[23]  B. Halliwell,et al.  Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.

[24]  J. Foreyt,et al.  Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men. , 1990, Metabolism: clinical and experimental.

[25]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[26]  A. I. Dorozhko,et al.  Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. , 1989, Biochemical pharmacology.

[27]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[28]  H. Esterbauer,et al.  A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. , 1989, Journal of lipid research.

[29]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Taskinen,et al.  Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men. , 1989, Metabolism: Clinical and Experimental.

[31]  H. Esterbauer,et al.  Continuous monitoring of in vitro oxidation of human low density lipoprotein. , 1989, Free radical research communications.

[32]  B. Ames,et al.  Antioxidant defenses and lipid peroxidation in human blood plasma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Gryglewski,et al.  Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.

[34]  O. Quehenberger,et al.  Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. , 1987, Journal of lipid research.

[35]  J. Cillard,et al.  Hydroxyl radical scavenging activity of flavonoids , 1987 .

[36]  J. Cillard,et al.  Antioxidant activity of flavonoids and reactivity with peroxy radical , 1986 .

[37]  C. Fiedler-Nagy,et al.  Effect of flavonoids on arachidonic acid metabolism. , 1986, Progress in clinical and biological research.

[38]  J. Maclouf,et al.  Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. , 1985, Biochimica et biophysica acta.

[39]  C. Alling,et al.  Effects of chronic ethanol treatment on lipid composition and prostaglandins in rats fed essential fatty acid deficient diets. , 1984, Alcoholism, clinical and experimental research.

[40]  M. Aviram Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. , 1983, Biochemical medicine.

[41]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[42]  J. Baumann,et al.  Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. , 1980, Prostaglandins.

[43]  H. Shio,et al.  Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. , 1979, Laboratory investigation; a journal of technical methods and pathology.

[44]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[45]  V. L. Singleton,et al.  Colorimetry of Total Phenolics with Phosphomolybdic-Phosphotungstic Acid Reagents , 1965, American Journal of Enology and Viticulture.

[46]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.